テストステロンが誘発した身体組成の変化のシーケンスと,薬が中止された後の変化の逆転
G B Forbes1, C R Porta, B E Herr
1Department of Pediatrics, University of Rochester, School of Medicine and Dentistry, NY 14642.
JAMA
|January 15, 1992
まとめ
高用量テストステロンは,体量 (LBM) を大幅に増加させ,体脂肪を減少させます. 体組成に対するこれらのアナボリック効果は,テストステロン治療の終了後にゆっくりと減少します.
科学分野:
- エンドクリノロジー エンドクリノロジー
- スポーツ医学 スポーツ医学
- ボディコンポジション分析 分析
背景:
- テストステロンは,重要なアナボリックホルモンです.
- 体組成に及ぼす影響を理解することは,臨床およびパフォーマンスのアプリケーションに不可欠です.
研究 の 目的:
- 高用量テストステロンの投与が身体組成に与える影響を調査する.
- 薬物中断後のこれらの変化の可逆性を評価する.
主な方法:
- 若い成人の男性は,テストステロンエナンサート注射を12週間にわたって毎週受けました.
- 痩身量 (LBM) は,カリウム40カウントを使用して測定されました.
- 体組成の変化は,治療中に,そして治療後の5~6ヶ月間,追跡された.
主要な成果:
- テストステロン治療は,LBMの漸進的な増加と体脂肪の減少につながった.
- 注射が止まった後,体構成は徐々にベースラインに戻り,長引く効果を示唆しました.
- 観察されたLBMの変化は,尿中のクレアチニン分泌と相関しています.
結論:
- テストステロンは強力なアナボリック剤として作用します.
- 体脂肪の量を効果的に減らすことができます.
- アナボリック効果と脂肪を減らす効果は,停止後もしばらく持続します.
関連する概念動画
Drug Biotransformation: Overview
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Drug Biotransformation: Overview
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
Phase I Reactions: Reductive Reactions
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
Chronopharmacokinetics: Time-Dependent Pharmacokinetics
Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...


